The Medicaid Drug Utilization Review (DUR) Board met on Thursday, September 15, 2016. The final report of the meeting can be viewed here.
The Hepatitis C summary can be found on page 4. At the meeting these changes were made to Medicaid Fee-For-Service:
- Epclusa (GT 2 and 3) was added to the preferred prescription medication list.
- Viekira XR was added to the preferred prescription medication list.
An archived audio cast of the meeting proceedings is available on the Department of Health website.
Last Updated on January 25, 2020 by HepFree NYC
